News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
858,297 Results
Type
Article (87252)
Company Profile (732)
Press Release (770287)
Multimedia
Podcasts (164)
Webinars (26)
Section
Business (232983)
Career Advice (4137)
Deals (39782)
Drug Delivery (133)
Drug Development (91209)
Employer Resources (201)
FDA (18248)
Job Trends (17387)
News (397215)
Policy (39901)
Tag
Academia (3003)
Academic (2)
Accelerated approval (17)
Adcomms (35)
Allergies (119)
Alliances (56979)
ALS (137)
Alzheimer's disease (1648)
Antibody-drug conjugate (ADC) (206)
Approvals (18243)
Artificial intelligence (456)
Autoimmune disease (49)
Automation (23)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (147)
Biotechnology (483)
Bladder cancer (118)
Brain cancer (47)
Breast cancer (439)
Cancer (3554)
Cardiovascular disease (312)
Career advice (3551)
Career pathing (36)
CAR-T (230)
CDC (49)
Cell therapy (631)
Cervical cancer (29)
Clinical research (74967)
Collaboration (1289)
Company closure (4)
Compensation (862)
Complete response letters (51)
COVID-19 (2941)
CRISPR (78)
C-suite (512)
Cystic fibrosis (130)
Data (3828)
Decentralized trials (2)
Denatured (58)
Depression (100)
Diabetes (426)
Diagnostics (7048)
Digital health (30)
Diversity (11)
Diversity, equity & inclusion (49)
Drug discovery (216)
Drug pricing (169)
Drug shortages (36)
Duchenne muscular dystrophy (183)
Earnings (98644)
Editorial (53)
Employer branding (25)
Employer resources (169)
Events (132446)
Executive appointments (957)
FDA (20494)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (4)
Frontotemporal dementia (11)
Funding (1141)
Gene editing (165)
Generative AI (45)
Gene therapy (499)
GLP-1 (1000)
Government (5350)
Grass and pollen (7)
Guidances (334)
Healthcare (20934)
HIV (48)
Huntington's disease (33)
IgA nephropathy (52)
Immunology and inflammation (224)
Immuno-oncology (18)
Indications (46)
Infectious disease (3160)
Inflammatory bowel disease (179)
Inflation Reduction Act (13)
Influenza (87)
Intellectual property (167)
Interviews (815)
IPO (17922)
IRA (59)
Job creations (5196)
Job search strategy (2863)
Kidney cancer (15)
Labor market (69)
Layoffs (626)
Leadership (31)
Legal (10144)
Liver cancer (90)
Longevity (12)
Lung cancer (512)
Lymphoma (251)
Machine learning (23)
Management (65)
Manufacturing (574)
MASH (119)
Medical device (14830)
Medtech (14848)
Mergers & acquisitions (22677)
Metabolic disorders (1083)
Multiple sclerosis (118)
NASH (23)
Neurodegenerative disease (184)
Neuropsychiatric disorders (50)
Neuroscience (2552)
NextGen: Class of 2025 (7687)
Non-profit (5095)
Now hiring (54)
Obesity (541)
Opinion (304)
Ovarian cancer (114)
Pain (155)
Pancreatic cancer (146)
Parkinson's disease (215)
Partnered (27)
Patents (386)
Patient recruitment (272)
Peanut (57)
People (66076)
Pharmaceutical (143)
Pharmacy benefit managers (25)
Phase I (23112)
Phase II (32555)
Phase III (24502)
Pipeline (2474)
Policy (281)
Postmarket research (3554)
Preclinical (10439)
Press Release (72)
Prostate cancer (175)
Psychedelics (49)
Radiopharmaceuticals (281)
Rare diseases (601)
Real estate (7412)
Recruiting (76)
Regulatory (27705)
Reports (64)
Research institute (2676)
Resumes & cover letters (650)
Rett syndrome (12)
RNA editing (15)
RSV (64)
Schizophrenia (121)
Series A (189)
Series B (141)
Service/supplier (30)
Sickle cell disease (75)
Special edition (24)
Spinal muscular atrophy (168)
Sponsored (40)
Startups (4315)
State (2)
Stomach cancer (17)
Supply chain (95)
Tariffs (83)
The Weekly (104)
Vaccines (1011)
Venture capital (63)
Weight loss (376)
Women's health (56)
Worklife (21)
Date
Today (149)
Last 7 days (539)
Last 30 days (2512)
Last 365 days (33938)
2025 (23836)
2024 (38139)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1278)
Alabama (78)
Alaska (7)
Arizona (297)
Arkansas (14)
Asia (50809)
Australia (8924)
California (8942)
Canada (2712)
China (844)
Colorado (378)
Connecticut (398)
Delaware (242)
Europe (116687)
Florida (1316)
Georgia (305)
Hawaii (3)
Idaho (67)
Illinois (787)
India (46)
Indiana (432)
Iowa (19)
Japan (270)
Kansas (122)
Kentucky (35)
Louisiana (20)
Maine (75)
Maryland (1218)
Massachusetts (6738)
Michigan (296)
Minnesota (541)
Mississippi (4)
Missouri (113)
Montana (32)
Nebraska (26)
Nevada (102)
New Hampshire (76)
New Jersey (2464)
New Mexico (31)
New York (2431)
North Carolina (1365)
North Dakota (10)
Northern California (3976)
Ohio (281)
Oklahoma (19)
Oregon (49)
Pennsylvania (1860)
Puerto Rico (18)
Rhode Island (44)
South America (1655)
South Carolina (45)
South Dakota (1)
Southern California (3405)
Tennessee (142)
Texas (1400)
United States (33161)
Utah (267)
Virginia (239)
Washington D.C. (82)
Washington State (768)
West Virginia (4)
Wisconsin (92)
There are 858,297 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
VectorY Therapeutics and Shape Therapeutics Announce Option and License Agreement to Advance Vectorized Antibodies for Neurodegenerative Diseases Using an AAV5-Derived CNS Capsid
September 18, 2025
·
4 min read
Press Releases
AIRSUPRA® (albuterol/budesonide) US prescribing information updated to reflect the statistically significant severe exacerbation risk reduction in patients with mild asthma compared with albuterol
September 18, 2025
·
13 min read
Press Releases
Seaport Therapeutics to Participate in Upcoming Investor Conferences - September 18, 2025
September 18, 2025
·
1 min read
Press Releases
Marengo Therapeutics Advances STARt-002 Clinical Trial into Phase 2 Cohort Expansion Evaluating Invikafusp Alfa with TROP2-directed ADC TRODELVY® in Metastatic Breast Cancer
September 18, 2025
·
4 min read
Press Releases
Novo Nordisk Canada and Pocketpills Announce Collaboration to Provide Enhanced Online Pharmacy and Prescription Services and Support for Ozempic® and Wegovy®
September 18, 2025
·
3 min read
Press Releases
BioCardia Announces CardiAMP Chronic Myocardial Ischemia Trial Top Line Data of Roll-in Cohort Show Improved Exercise Tolerance and Reduced Angina Episodes at Six-Month Primary Follow-up
September 18, 2025
·
7 min read
Press Releases
Humacyte Announces Publication of Preclinical Data on Use of the CTEV as a Coronary Artery Bypass Graft (CABG)
September 18, 2025
·
8 min read
Press Releases
BioXcel Therapeutics Regains Compliance with Nasdaq Market Value of Listed Securities Requirements
September 18, 2025
·
6 min read
Press Releases
Cullgen Completes Enrollment in Phase 1 Trial of its Novel Non-Opioid Pain Product Candidate CG001419
September 18, 2025
·
6 min read
Press Releases
NucleoBio and PreCheck Health Services Announce Strategic Collaboration to Advance Non-Invasive Prostate Cancer Testing
September 18, 2025
·
5 min read
1 of 85,830
Next
